Skip to main content
. Author manuscript; available in PMC: 2017 Jan 10.
Published in final edited form as: Exp Lung Res. 2012 Jun 28;38(7):325–332. doi: 10.3109/01902148.2012.700760

TABLE 2.

Aerosol Characterization

Device Solution Air flow rate
(LPM)
Aerosol conc. of AlPCS
(mg/L)
MMAD(µm) GSD
Medi-nuclear 10 mg/mL AlPSC 2 0.14a 0.2a 1.84a
Medi-nuclear 10 mg/mL AlPSC + 100 mg/mL CsCl 2 0.14b 0.4b 1.8b
Aeroneb 2 mg/mL AlPSC + 6 mg/mL CsCl +Column 0.4 1.48 1.6 1.82
Aeroneb 10 mg/mL AlPSC 0.4 7.98 4.0 1.84

Note. Compiled data providing the type of device and solution used to generate the aerosol with the given air flow rate, aerosol concentration in terms of the concentration of ALPCS per volume of air, and particle size distribution (mass median aerodynamic diameter, MMAD, and geometric standard deviation, GSD). The particle size distribution obtained with the Medi-nuclear was derived from the results of the SMPS and aerosol concentrations were calculated from filter capture measurements.

a

Data taken from [18].

b

Data taken from [20].